CN101579334A - Composite preparation composed of nervonic acid and curcumin - Google Patents
Composite preparation composed of nervonic acid and curcumin Download PDFInfo
- Publication number
- CN101579334A CN101579334A CNA2009100945700A CN200910094570A CN101579334A CN 101579334 A CN101579334 A CN 101579334A CN A2009100945700 A CNA2009100945700 A CN A2009100945700A CN 200910094570 A CN200910094570 A CN 200910094570A CN 101579334 A CN101579334 A CN 101579334A
- Authority
- CN
- China
- Prior art keywords
- curcumin
- nervonic acid
- composition
- vitamin
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to a composite preparation composed of nervonic acid, curcumin, multi-mineral matter and multi-vitamin, wherein, the composite preparation is prepared from the following raw materials by weight percentage: 1-90% of nervonic acid; 1-90% of curcumin; 0-80% of multi-mineral matter; 0-80% of multi-vitamin; 1-50% of granule, tablet and capsule excipient; the raw materials are prepared into granules, capsules and tablets. The composite preparation can provide nervonic acid, curcumin, mineral matter and vitamin required by human body.
Description
Technical field:
The present invention relates to a kind of compound formulation of forming by nervonic acid, curcumin.Nervonic acid, the curcumin that can provide needed by human body to want.
Background technology:
Nervonic acid involved in the present invention is found in mammiferous nervous tissue the earliest, is biomembranous important composition composition in the nervous tissue, is the significant composition of medullary substance in the brain glycoside.Being mainly derived from shark brain and shark oil at present, is the products and health products additive agent of new generation that the domestic and international utmost point is favored.
Nervonic acid be the various countries scientist generally acknowledge in the world first, also be that impaired cerebral nerve path---nerve fiber is dredged in a unique energy reparation, and impel the magical material of economic benefits and social benefits of nervous cell regenerating.
Nervonic acid is the core natural component of cerebral nerve fiber and neurocyte.The shortage of nervonic acid will cause disease of brain such as apoplexy sequela, senile dementia, cerebral palsy, brain atrophy, hypomnesis, insomnia forgetfulness.The nervonic acid human body self is difficult to again generate, and can only lean on external picked-up to replenish
The complete penetrating blood brain barrier of crossing of nervonic acid energy; directly act on nerve fiber and repair mediation; allow protection sheath impaired, that come off regenerate; the slough of dissolving blocking channel; induce the oneself's growth and the division of nerve fiber; information and extraneous information that neurocyte is produced can both be smoothly by the nerve fiber transmission; reach direct orders; activate the neurocyte of impaired, pathological changes and dormancy with this; reinvent neutral net; recover the part or all of function of patient, reach the thorough rehabilitation of encephalopathy at aspects such as language, memory, sensation, limbs.
Curcumin is a kind of antiinflammatory that has, and is antibiotic, the antioxidant of antiviral and antibacterium effect.Curcumin can help to prevent Alzheimer's disease.This is a kind of old people's of being common in a disease, and the patient can have a lapse of memory, and loses ability of thinking.Curcumin can well reduce the chance of suffering from Alzheimer's disease.Take in curcumin and can resist infected material, and help the attack of immune system defence disease.
Minerals and vitamins also is the material that human body need replenish, and several persons are put in the same preparation, can replenish simultaneously, avoids taking simultaneously many medicines.
Summary of the invention:
The purpose of this invention is to provide a kind of compound formulation with multiple efficacies.This compound formulation has certain effect to disease of brain such as apoplexy sequela, senile dementia, cerebral palsy, brain atrophy, hypomnesis, insomnia forgetfulness, can replenish the minerals and vitamins of needed by human body simultaneously.
This compound formulation is characterised in that by following raw materials by weight percent to be made: nervonic acid 1-90%, curcumin 1-90%, composite mineral matter 0-80%, compound vitamin 0-80%, granule, tablet, capsule excipient 1-50%.Composite mineral matter is by all or part of composition of calcium, phosphorus, ferrum, magnesium, zinc, potassium, manganese, chromium, molybdenum, selenium, nickel, stannum, silicon, vanadium, iodine that can be edible.Compound vitamin is by all or part of composition of vitamin D, A, E, C, B1, B2, B6, B12, K, folic acid, nicotiamide, pantothenic acid that can be edible.
Specific embodiment
Further set forth the present invention below in conjunction with specific embodiment, but not as limitation of the present invention.
Embodiment 1:
Nervonic acid 6kg; Curcumin 6kg; Excipient 3kg.Make tablet according to method for preparing tablet thereof.
Embodiment 2:
Nervonic acid 3kg; Curcumin 2kg; Composite mineral matter 5kg; Compound vitamin 2kg; Excipient 3kg.
Make tablet according to method for preparing tablet thereof.
Claims (4)
1. compound formulation of forming by nervonic acid, curcumin.It is characterized in that said composition contains nervonic acid and curcumin; Nervonic acid and curcumin are made up of following percentage by weight: nervonic acid 1-90%, curcumin 1-90%.
2, compound formulation according to claim 1 is characterized in that said composition also can add composite mineral matter, and the percentage by weight of its addition is 0-80%.Wherein composite mineral matter is by all or part of composition of calcium, phosphorus, ferrum, magnesium, zinc, potassium, manganese, chromium, molybdenum, selenium, nickel, stannum, silicon, vanadium, iodine that can be edible.
3, compound formulation according to claim 1 is characterized in that said composition also can add compound vitamin, and the percentage by weight of its addition is 0-80%.Wherein compound vitamin is by all or part of composition of vitamin D, A, E, C, B1, B2, B6, B12, K, folic acid, nicotiamide, pantothenic acid that can be edible.
4. compound formulation according to claim 1, wherein the excipient of granule, tablet, capsule comprises diluent, absorbent, disintegrating agent, binding agent, wetting agent, lubricant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100945700A CN101579334A (en) | 2009-06-12 | 2009-06-12 | Composite preparation composed of nervonic acid and curcumin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2009100945700A CN101579334A (en) | 2009-06-12 | 2009-06-12 | Composite preparation composed of nervonic acid and curcumin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101579334A true CN101579334A (en) | 2009-11-18 |
Family
ID=41361742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2009100945700A Pending CN101579334A (en) | 2009-06-12 | 2009-06-12 | Composite preparation composed of nervonic acid and curcumin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101579334A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700088621A1 (en) * | 2017-08-01 | 2019-02-01 | Inpha Duemila Srl | Food supplements for use in the treatment of diseases associated with alterations of peripheral nerve trophism. |
| CN109805390A (en) * | 2019-02-27 | 2019-05-28 | 云南大学 | A kind of calcium nervonate, nervonic acid zinc and vitamin K2Compound composition soft capsule |
| CN113197879A (en) * | 2021-05-26 | 2021-08-03 | 秦硕卿 | Nervonic acid microcapsule and preparation method thereof |
-
2009
- 2009-06-12 CN CNA2009100945700A patent/CN101579334A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700088621A1 (en) * | 2017-08-01 | 2019-02-01 | Inpha Duemila Srl | Food supplements for use in the treatment of diseases associated with alterations of peripheral nerve trophism. |
| EP3437638A1 (en) * | 2017-08-01 | 2019-02-06 | Inpha Duemila S.r.l. | Nervonic acid and curcumin for the treatment of pathologies associated with peripheral nerves trophism alterations |
| CN109805390A (en) * | 2019-02-27 | 2019-05-28 | 云南大学 | A kind of calcium nervonate, nervonic acid zinc and vitamin K2Compound composition soft capsule |
| CN113197879A (en) * | 2021-05-26 | 2021-08-03 | 秦硕卿 | Nervonic acid microcapsule and preparation method thereof |
| CN113197879B (en) * | 2021-05-26 | 2022-10-11 | 山东洁静精微医药科技有限公司 | Nervonic acid microcapsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102178634B (en) | Pearl essence skin-whitening prickly heat powder | |
| CN103156898A (en) | Compound preparation of nervonic acid and panax notoginseng total saponins and preparation method of compound preparation | |
| CN101579334A (en) | Composite preparation composed of nervonic acid and curcumin | |
| CN105918587A (en) | Acer truncatum seed oil tabletting candies and preparation method thereof | |
| CN101584712A (en) | A kind of compound formulation of forming by nervonic acid, composite mineral matter, compound vitamin | |
| Ali et al. | ANTICONVULSANT EFFECT OF SEED EXTRACT OF CAESALPINIA BONDUCELLA (ROXB.) | |
| CN101721616A (en) | Medicine for stopping bleeding | |
| CN103070989A (en) | Tablet and a preparation method thereof | |
| CN103735830B (en) | One is treated osteoporotic Chinese medicine composition | |
| CN101234149A (en) | Composition for treating pain of head, face and limbs and various tendons clonic convulsion and preparation thereof | |
| CN102357166B (en) | Brain tonic powder and application thereof | |
| CN102846513A (en) | Hircismus removing agent | |
| CN101019990A (en) | Chinese medicine for treating lobar pneumonia | |
| CN102579806B (en) | Drug combination for treating schizophrenia | |
| CN104173499A (en) | Medicine treating constipation | |
| CN104784378B (en) | A kind of medicament for the treatment of primary trigeminal neuralgia | |
| Abe | A patient developed painful muscle cramps due to overeating mangos | |
| CN103656526B (en) | A kind of Chinese medicine composition being used for the treatment of eczema and skin pruritus | |
| CN102961520B (en) | Pharmaceutical composition for treating arthritis and method for preparing pharmaceutical composition for treating arthritis | |
| CN101721541A (en) | Medicine for treating erysipelas | |
| CN103381265A (en) | Traditional Chinese medicine for treating simple roundworm ileus | |
| CN104107204A (en) | Medicinal composition for treating encephalatrophy and facial paralysis | |
| CA2860159C (en) | Peptides targeting receptor activator of nuclear factor-kappa b (rank) and their applications | |
| CN102204989B (en) | Pharmaceutical composition for treating rheumatism | |
| CN102462800A (en) | Traditional Chinese medicine composition for treatment of recurrent cough |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20091118 |